Panacea Biotec vs Peers
- Market cap
- ₹2,122 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹249.48 – ₹467.78
Panacea Biotec ranks 1st by market capitalisation among 1 Biotechnology companies tracked by ATS. Its largest peers are Panacea Biotec. Its P/E of 22.5 compares with a peer median of 22.5.
Panacea Biotec vs Biotechnology peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Panacea Biotec | 346.50 | +0.58% | 2,122 | 22.5 | 2.85 | 14.5% | +18.5% |
| Panacea Biotec | 346.50 | +0.58% | 2,122 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Panacea Biotec peer comparison — frequently asked questions
Who are Panacea Biotec's competitors?
Panacea Biotec's listed peers in Biotechnology include Panacea Biotec, ranked here by market capitalisation.
How does Panacea Biotec's P/E compare with its peers?
Panacea Biotec trades at a P/E of 22.5, against a median of 22.5 across the 1 Biotechnology peers shown.
Which is the largest company among Panacea Biotec's peers?
By market capitalisation, the largest company in the group is Panacea Biotec at ₹2,122 crore, against ₹2,122 crore for Panacea Biotec.
Same Data For Peers
Trade Panacea Biotec With ATS
Track PANACEABIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.